B-Cell Targeted Therapies in Systemic Lupus Erythematosus.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 85, doi. 10.1007/s40259-013-0015-8
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2013 AND VI 27 AND IP 2
Results: 6
1
2
A Novel Approach to Improve the Function of FGF21.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 159, doi. 10.1007/s40259-013-0013-x
- By:
- Publication type:
- Article
3
Differences Between Post-Authorization Adverse Drug Reactions of Biopharmaceuticals and Small Molecules.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 167, doi. 10.1007/s40259-013-0012-y
- By:
- Publication type:
- Article
4
Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 149, doi. 10.1007/s40259-013-0010-0
- By:
- Publication type:
- Article
5
Platelet-Rich Plasma to Improve the Bio-Functionality of Biomaterials.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 97, doi. 10.1007/s40259-012-0004-3
- By:
- Publication type:
- Article
6
Immunotherapy of Multiple Sclerosis.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 113, doi. 10.1007/s40259-013-0011-z
- By:
- Publication type:
- Article